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Reduced‑port totally robotic distal 
subtotal gastrectomy for gastric 
cancer: 100 consecutive cases 
in comparison with conventional 
robotic and laparoscopic distal 
subtotal gastrectomy
Won Jun Seo1, taeil Son2,3,4*, Hyejung Shin5, Seohee choi2, chul Kyu Roh6, Minah cho2,3, 
Hyoung‑il Kim2,3,4 & Woo Jin Hyung2,3
By overcoming technical difficulties with limited access faced when performing reduced-port surgery 
for gastric cancer, reduced-port totally robotic gastrectomy (RPRDG) could be a safe alternative to 
conventional minimally invasive gastrectomy. An initial 100 consecutive cases of RPRDG for gastric 
cancer were performed from February 2016 to September 2018. Short-term outcomes for RPRDG 
with those for 261 conventional laparoscopic (CLDG) and for 241 robotic procedures (CRDG) over the 
same period were compared. Learning curve analysis for RPRDG was conducted to determine whether 
this procedure could be readily performed despite fewer access. During the first 100 cases of RPRDG, 
no surgeries were converted to open or laparoscopic surgery, and no additional ports were required. 
RPRDG showed longer operation time than CLDG (188.4 min vs. 166.2 min, p < 0.001) and similar 
operation time with CRDG (183.1 min, p = 0.315). The blood loss was 35.4 ml for RPRDG, 85.2 ml for 
CLDG (p < 0.001), and 41.2 ml for CRDG (p = 0.33). The numbers of retrieved lymph nodes were 50.5 for 
RPRDG, 43.9 for CLDG (p = 0.003), and 55.0 for CRDG (p = 0.055). Postoperative maximum C-reactive 
protein levels were 96.8 mg/L for RPRDG, 87.8 mg/L for CLDG (p = 0.454), and 81.9 mg/L for CRDG 
(p = 0.027). Learning curve analysis indicated that the overall operation time of RPRDG stabilized 
at 180 min after 21 cases. The incidence of major postoperative complications did not differ among 
groups. RPRDG for gastric cancer is a feasible and safe alternative to conventional minimally invasive 
surgery. Notwithstanding, this procedure failed to reduce postoperative inflammatory responses.
With the accumulation of personal and institutional experiences and with the development of laparoscopic 
instruments since the first reported laparoscopic gastrectomy with lymph node  dissection1, experienced surgeons 
have successfully shifted to more advanced procedures, such as reduced-port or single-incision laparoscopic 
gastrectomy, for gastric  cancer2–6. Reduced-port laparoscopic gastrectomy was developed in expectation of better 
short-term surgical outcomes by reducing surgical insults to the patients. However, other than better cosmetic 
results, its outcomes appear to be similar to those of conventional laparoscopic  surgery3,5, and surgeons have 
raised concerns for its technical and oncology safety due to a limited number of access points that leads to intra- 
and extracorporeal  collisions7,8.
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As an alternative to reduced-port laparoscopic gastrectomy, we previously introduced reduced-port totally 
robotic  gastrectomy9,10. In our initial experience, we found that this procedure alleviated many of the ergonomic 
and technical difficulties encountered when performing reduced-port laparoscopic gastrectomy. Moreover, apply-
ing the reduced-port totally robotic procedure, we were able to successfully conduct D2 lymph node dissection 
and perform technically challenging anastomosis, such as intracorporal delta-shape gastroduodenostomy, with-
out compromising short-term surgical outcomes. However, there were limitations to our reports on this initial 
experience because they involved non-comparative analysis and small sample sizes.
Thus, in this study, we sought to investigate the short-term outcomes of our initial 100 consecutive cases 
of reduced-port totally robotic distal subtotal gastrectomy, comparing them with the short-term outcomes of 
conventional laparoscopic and robotic distal subtotal gastrectomy.
Results
Patient characteristics. Patient characteristics are outlined in Table 1. Mean age was 54.5 years in the 
RPRDG group, 62.0 years in the CLDG group (p < 0.001) and 57.2 years in the CRDG group (p = 0.059). Mean 
BMI values were 23.8, 23.5, and 23.6, respectively, and differences therein showed no statistical significance in 
each comparison (RPRDG vs. CLDG; p = 0.544, RPRDG vs. CRDG; p = 0.689). While the CLDG group showed 
a higher proportion of patients with worse ASA score (p = 0.001) than the RPRDG group, ASA scores for CRDG 
and RPRDG were similar (p = 0.383). Clinical T, N classification and tubular, circular tumor location were simi-
lar between the RPRDG and CLDG groups (p = 0.216, 0.422, 0.378, and 0.919, respectively) and between the 
RPRDG and CRDG groups (p = 0.852, 1, 0.18, and 0.794, respectively).
Operative and pathologic outcomes (Table 2). There were no open or laparoscopic conversions or 
additional port insertions during any procedure. D2 lymph node dissection rate was higher in the RPRDG 
group (27%) than in the CLDG group (17.6%), although the difference was not statistically significant 
(p = 0.066). Between the RPRDG and CRDG groups, D2 lymph node dissection rates were similar (26.1% in 
CRDG, p = 0.804). Reconstruction was primarily achieved by BI anastomosis in all groups, although the rate 
was significantly higher in the RPRDG group (91.0%) than in the CLDG (75.9%, p = 0.005) and CRDG groups 
Table 1.  Patient characteristics. Values are shown mean ± standard deviation or n(%). a Clinical stages 






(n = 261) p value
Conventional robotic
(n = 241) p value
Age (years) 54.5 ± 11.4 62.0 ± 11.5  < 0.001 57.2 ± 12.1 0.059
Sex 0.733 0.505
Male 59 (59.0) 147 (56.3) 131 (54.4)
Female 41 (41.0) 114 (43.7) 100 (45.6)
ASA score 0.001 0.383
1 24 (24.0) 39 (14.9) 63 (26.1)
2 62 (62.0) 129 (49.4) 129 (53.5)
3 14 (14.0) 86 (33.0) 47 (19.5)
4 0 (0) 7 (2.7) 2 (0.8)
BMI, kg/m2 23.8 (2.7) 23.5 (3.1) 0.544 23.6 (2.9) 0.689
Clinical T classificationa 0.216 0.852
cT1 74 (74.0) 212 (81.2) 185 (76.8)
cT2 21 (21.0) 41 (15.7) 48 (19.9)
cT3 4 (4.0) 8 (3.1) 7 (2.9)
cT4 1 (1.0) 0 (0.0) 1 (0.4)
Clinical N classificationa 0.422  > 0.99
N0 89 (89.0) 241 (92.3) 214 (88.8)
N1 11 (11.0) 20 (7.7) 27 (11.2)
Tubular tumor location 0.378 0.18
Middle third 67 (67.0) 160 (61.3) 141 (58.5)
Lower third 33 (33.0) 101 (38.7) 100 (41.5)
Circular tumor location 0.919 0.794
Lesser curvature 33 (33.0) 94 (36.0) 88 (36.5)
Greater curvature 19 (19.0) 56 (21.5) 49 (20.3)
Anterior wall 21 (21.0) 47 (18.0) 37 (15.4)
Posterior wall 26 (26.0) 62 (23.8) 65 (27.0)
Circular 1 (1.0) 2 (0.8) 2 (0.8)
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(75.1%, p = 0.003). Operation time was significantly longer for RPRDG than for CLDG (188.4 min vs. 166.2 min, 
p < 0.001) and was similar between RPRDG and CRDG (183.1  min, p = 0.315). Estimated blood loss in the 
RPRDG group was significantly less than that in the CLDG group (35.4 ml vs. 85.2 ml, p < 0.001), but similar to 
that in the CRDG group (41.2 ml, p = 0.33). The mean number of retrieved lymph nodes in the RPRDG group 
was significantly larger than that in the CLDG group (50.5 vs. 43.9, p = 0.003), but similar to that in the CRDG 
group (55.0, p = 0.055). The median number of retrieved lymph nodes in the RPRDG group was still larger than 
that in the CLDG group (44.5 vs. 42.0, p = 0.011), however significantly smaller to that in the CRDG group 
(53.0, p = 0.018). One patient in the RPRDG group underwent R1 resection due to a positive proximal margin, 
although frozen section biopsy showed the proximal margin involvement to be false negative.
Table 2.  Operative and pathologic outcomes. Values are shown mean ± standard deviation or n(%). a Stages are 





(n = 261) p value
Conventional robotic
(n = 241) p value
Open or laparoscopic conversion 0 (0) 0 (0) – 0 (0) –
Lymph node dissection 0.066 0.804
D1 0 (0.0) 0 (0.0) 1 (0.4)
D1 + 73 (73.0) 215 (82.4) 177 (73.4)
D2 27 (27.0) 46 (17.6) 63 (26.1)
Reconstruction 0.005 0.003
BI 91 (91.0) 198 (75.9) 181 (75.1)
BII 8 (8.0) 52 (19.9) 45 (18.7)
Roux-en-Y 1 (1.0) 11 (4.2) 15 (6.2)
Omentectomy 0.908 0.679
Partial 96 (96.0) 248 (95.0) 227 (94.2)
Total 4 (4.0) 13 (5.0) 14 (5.8)
Combined resection 0.47 0.145
No 94 (94.0) 230 (88.1) 236 (97.9)
Gallbladder 4 (4.0) 21 (8.0) 2 (0.8)
Colon 0 (0.0) 2 (0.8) 1 (0.4)
Ovary 0 (0.0) 2 (0.8) 0 (0.0)
Others 2 (2.0) 6 (2.3) 2 (2.0)
Operation time (min) 188.4 ± 40.3 166.2 ± 58.4  < 0.001 183.1 ± 50.7 0.315
Blood loss (ml) 35.4 ± 40.8 85.2 ± 95.2  < 0.001 41.2 ± 66.4 0.33
No. retrieved lymph node 50.5 ± 20.2 43.9 ± 18.1 0.003 55.0 ± 19.6 0.055
Median (range) No. of retrieved lymph 
node 44.5 (17–119) 42.0 (8–156) 0.011 53.0 (16–130) 0.018
No. metastatic lymph node 0.7 ± 2.4 0.6 ± 1.9 0.601 1.3 ± 6.2 0.187
Proximal margin (mm) 40.3 ± 22.7 46.4 ± 28.1 0.034 41.1 ± 26.5 0.782
Proximal margin involvement 1 (1.0) 0 (0.0) 0.618 0 (0.0) 0.649
Distal margin (mm) 54.3 ± 36.4 58.3 ± 36.0 0.349 63.0 ± 36.8 0.047
Distal margin involvement 0 (0.0) 0 (0.0) – 0 (0.0) –
Histologic type 0.007 0.079
Well differentiated 14 (14.0) 24 (9.2) 22 (9.1)
Moderately differentiated 17 (17.0) 98 (37.5) 73 (30.3)
Poorly differentiated 43 (43.0) 77 (29.5) 78 (32.4)
Mucinous 0 (0.0) 1 (0.4) 1 (0.4)
Signet ring cell 23 (23.0) 55 (21.1) 63 (26.1)
Others 3 (3%) 6 (2.3) 4 (1.7)
pTNM  stagea 0.887 0.816
IA 74 (74.0) 203 (77.8) 179 (74.3)
IB 10 (10.0) 24 (9.2) 20 (8.3)
IIA 5 (5.0) 14 (5.4) 12 (5.0)
IIB 3 (3.0) 8 (3.1) 11 (4.6)
IIIA 6 (6.0) 9 (3.4) 9 (3.7)
IIIB 2 (2.0) 3 (1.1) 7 (2.9)
IIIC 0 (0.0) 0 (0.0) 3 (1.2)
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Postoperative outcomes (Table 3). Resumption of a soft diet and the length of hospital stay in the 
RPRDG group did not differ from those in the CLDG group (4.9 days vs. 4.7 days, p = 0.587 and 6.6 days vs. 
6.6 days, p = 0.947, respectively), but were longer than those in the CRDG group (4.0 days, p = 0.02 and 5.4 days, 
p = 0.008, respectively). Postoperative laboratory test results were similar, except for maximum C-reactive protein 
(CRP), which was greater in the RPRDG group than in the CRDG group (96.8 vs. 81.9, p = 0.027). Postoperative 
CRP, WBC, hemoglobin, and albumin levels among the study groups at POD 1, 2, 3, and 5 are depicted in Fig. 1. 
Although the RPRDG group showed the highest levels of CRP among the three groups, they became similar to 
those of the other procedures at POD 5. Also, we found no significant difference between RPRDG and other 
groups in postoperative WBC, hemoglobin, or albumin levels. Rates of in-hospital major complications and 
readmission associated with major surgical complication were similar among the groups. In the RPRDG group, 
one grade IIIb, major in-hospital complication occurred due to intestinal obstruction that required re-operation; 
there were no readmissions due to major complications. In the CLDG group, two major in-hospital complica-
tions of postoperative pneumonia and intraabdominal fluid collection were recorded. One patient in the CLDG 
group was readmitted on POD 19 due to anastomosis leakage that was treated with percutaneous drainage. In 
the CRDG group, there were three major in-hospital complications of postoperative cardiac arrhythmia, wound 
complication, and sudden cardiac arrest. Also, three patients treated with CRDG were readmitted due to major 
complications of duodenal stump leakage, gastric ulcer bleeding, and intraabdominal bleeding. There were two 
mortality cases, which occurred only in the CRDG group: one case involved sudden cardiac arrest of suspected 
cardiac origin on POD 7, and the other involved hypovolemic shock due to intraabdominal bleeding at POD 26 
after readmission.
Learning curve analysis for RPRDG. The actual operation times for RPRDG are drawn in Fig. 2A. Ini-
tial operation times ranged from 200 to 300 min, which decreased to less than 200 min at around 20 cases. The 
results of fitted operation time analysis with the nonlinear regression model in Eq. (1). are plotted in Fig. 2B. The 
overall operation time stabilized at 180 min after 21 cases, a reduction of 120 min from the first case of RPRDG. 
We also used a nonlinear regression model with linear combinations (Eq. 2) to adjust for confounding factors 
affecting the operation time of RPRDG. According to this analysis, the fitted operation time stabilized at 101 min 
after 16 cases, for a reduction of 130 min (Fig. 2C). Among the confounding factors accounted for in the fitted 
analysis, age (0.48 min), D2 lymph node dissection (42.08 min, reference to D1 +), and BII or RY reconstruction 
(9.58 min, reference to BI) were statistically significant (eTable 1).
Discussion
In this study, we demonstrated the technical feasibility and safety of RPRDG for gastric cancer. Over our initial 
100 consecutive procedures, we have not experienced any open or laparoscopic conversion or additional port 
insertion due to technical difficulties. Also, learning curve analysis of our initial 100 RPRDG procedures showed 
an acceptable stabilized operation time of 180 min within 21 cases, which was faster than what we encountered 
for laparoscopic reduced-port  procedures6,11–13. Other short-term surgical outcomes of RPRDG were compa-
rable to those for CLDG performed by the same surgeon and for CRDG performed by another surgeon with 
considerable experience in this field. Notwithstanding, RPRDG failed to facilitate improvements in postoperative 
inflammatory markers, compared with conventional minimally invasive surgery groups.
Unlike conventional laparoscopic gastrectomy, which has a reported learning curve of more than 50  cases14–16, 
robotic gastrectomy has a learning curve of 10–20  cases12,17. Recent reports have shown that reduced-port or 
single-incision laparoscopic gastrectomy conducted by experienced laparoscopic surgeons reaches stabilized 
Table 3.  Postoperative outcomes. Values are shown mean ± standard deviation or n(%). a Major complication 





(n = 261) p value
Conventional robotic
(n = 241) p value
Bowel function recovery (days) 3.3 ± 0.8 3.3 ± 1.1 0.744 3.2 ± 0.7 0.27
Soft diet (days) 4.9 ± 3.5 4.7 ± 2.1 0.587 4.0 ± 0.4 0.02
Hospital stay (days) 6.6 ± 4.5 6.6 ± 3.5 0.947 5.4 ± 1.1 0.008
Maximum WBC (10^3/µL) 13.7 ± 3.3 13.1 ± 3.3 0.053 13.0 ± 3.5 0.106
Minimum Hemoglobin (g/dL) 11.3 ± 1.4 11.0 ± 1.4 0.213 11.4 ± 1.4 0.742
Minimum Albumin (g/dL) 3.4 ± 0.3 3.3 ± 0.3 0.164 3.4 ± 0.3 0.367
Maximum C-reactive protein (mg/L) 96.8 ± 57.4 87.8 ± 54.2 0.454 81.9 ± 56.1 0.027
Major  complicationa 1 1
No 99 (99.0) 259 (99.2) 238 (98.8)
Yes 1 (1.0) 2 (0.8) 3 (1.2)
Readmission due to major 
 complicationb – 0.629
No 100 (100.0) 251 (99.6) 238 (98.8)
Yes 0 (0.0) 1 (0.4) 3 (1.2)
Mortalityb 0 (0.0) 0 (0.0) 2 (0.8)
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operation times after 30–506,11–13. In our learning curve analysis, RPRDG showed results similar to those for 
conventional robotic  gastrectomy12. We presumed that this was because RPRDG is able to reduce the technical 
difficulties with reduced-port laparoscopic gastrectomy, especially in intra- and extra-corporeal collisions, which 
are the main hindrances in this surgery. However, when we analyzed factors influencing the operation time of 
RPRDG, older age, lymph node dissection greater than D1 + , and anastomosis other than BI were related to 
longer operation times during the RPRDG procedure. These results were different from a previous  report12, and 
imply that limited access and a narrow range of motion for robotic instruments in reduced-port gastrectomy 
still exist, even with the current robotic surgical system.
In this study, objective postoperative inflammatory markers, such as CRP and WBC  count18, did not differ 
among the surgery groups. We hypothesized that if RPRDG could decrease injury to the abdominal wall by 
reducing the number of incisions, then inflammatory markers during the postoperative period might be lowered, 
compared with conventional laparoscopic or robotic surgery. According to our analysis, however, maximum 
CRP and WBC counts for RPRDG were no better than those for other conventional procedures. Moreover, 
maximum CRP was higher in the RPRDG group than in the other surgery groups in the earlier postoperative 
period, although they were similar at the time of discharge. Considering other surgical variables that could 
affect the inflammatory process, for instance, D2 lymph node dissection, the rates of which were similar among 
the groups, we suspect that a longer operation time and the 2.5-cm incision that was made at the beginning of 
the procedure were the primary causes of these results. Also, similar results were described in a prior study of 
reduced-port laparoscopic  gastrectomy3. Nevertheless, postoperative morbidity and mortality may not be affected 
by a slight increase in inflammatory markers in the early post-operative period, and we have not experienced 
any incisional hernia in the infraumbilical or port incisions during follow up after RPRDG.
RPRDG was designed to emulate CRDG. In terms of surgical outcomes, operation time, blood loss, and the 
number of retrieved lymph nodes were similar between the two procedures. Meanwhile, a longer operation time 
for robotic gastrectomy, compared with laparoscopic surgery, which has been reported in previous  studies19,20, 
was noted in the current study. However, compared with CLDG, RPRDG was able to decrease estimated blood 
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Figure 1.  Changes in postoperative laboratory results until postoperative day 5 for reduced-port robotic, 
conventional laparoscopic, and conventional robotic distal subtotal gastrectomy. (A) C-reactive protein; (B) 
white blood cell counts; (C) hemoglobin; (D) albumin.
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Figure 2.  Learning curve analysis of reduced-port totally robotic gastrectomy. (A) Actual operation times for 
reduced-port totally robotic distal subtotal gastrectomy. (B) Fitted operation times by a nonlinear regression 
model for reduced-port totally robotic distal subtotal gastrectomy (A, stable operation time; C, converged case 
number). (C) Fitted operation time after adjusting for confounding variables of reduced-port totally robotic 
distal subtotal gastrectomy (A, stable operation time; C, converged case number).
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20 more minutes to lose less blood and to retrieve more lymph nodes may be acceptable. Accordingly, we deemed 
RPRDG to be comparable to other conventional procedures.
This is the first comparative study of 100 consecutive cases of reduced-port robotic distal subtotal gastrectomy 
for gastric cancer. Herein, we were able to demonstrate the feasibility and safety of our reduced-port robotic 
procedure, which showed a shorter learning curve and comparable short-term outcomes with conventional 
minimally invasive surgeries. This study did, however, have a couple of limitations. First, it was a study with 
a retrospective design. Second, RPRDG was only compared with conventional robotic surgery performed by 
another surgeon, since the operator of RPRDG has continued to perform all robotic procedures in a reduced-port 
fashion since its implementation. Third, we could not compare RPRDG with another reduced-port procedure 
because reduced-port laparoscopic gastrectomy is not performed in our institution. Finally, although we ana-
lyzed postoperative inflammatory markers of the procedures, we did not assess postoperative quality of life and 
cosmetic satisfaction with the procedures as evaluated by the patients. Due to the limitations listed above, there 
may be issues in generalizing the results of the current study. In particular, the results of comparing reduced-port 
robotic gastrectomy with conventional surgery by the experts in the field of robotic gastrectomy may be difficult 
to apply in countries other than Korea.
In conclusion, while this study only describes our initial experience, RPRDG showed short-term outcomes 
comparable to conventional laparoscopic and robotic gastrectomy. Although operation times were a bit longer 
for RPRDG, they were acceptable, and the number of cases to overcome the learning curve was only around 
20 cases, after which operation times became shorter. However, we did not observe decreased surgery-related 
stress for RPRDG, compared to conventional procedures, and further studies are required to justify the real 
benefits of RPRDG procedure over laparoscopic reduced-port surgery. Prospective trials are needed to provide 
more confirmative results on the short-term and long-term outcomes of various types of reduced-port robotic 
surgeries in comparison with conventional minimally invasive surgeries.
patients and method
Patients. We retrospectively reviewed a prospective collected database of gastric cancer patients treated at 
Severance Hospital, Yonsei University College of Medicine. Between February 2016 and September 2018, 362 
patients underwent distal subtotal gastrectomy for gastric cancer with a minimally invasive approach by a single 
surgeon. There were 100 consecutive reduced-port totally robotic surgery cases and 261 conventional laparo-
scopic surgery cases. One patient during the study period underwent conventional five-port robotic distal sub-
total gastrectomy combined with radical prostatectomy for prostate cancer and was excluded from analysis. Dur-
ing the same period, another surgeon (WJH) performed 241 conventional robotic distal subtotal gastrectomies.
The indication for minimally invasive surgery was early gastric cancer beyond the indication of endoscopic 
submucosal dissection or serosa negative advanced gastric cancer. Preoperative staging was assessed by endos-
copy with or without endoscopic ultrasound and by abdomino-pelvic computed tomography. All patients pro-
vided informed consent for surgery, including available minimally invasive surgery procedures. In cases in which 
serosal involvement was suspected during preoperative evaluation, minimally invasive surgery was carried out 
at the patient’s request. This retrospective study was approved by the Institutional Review Board of Severance 
Hospital, Yonsei University College of Medicine (4-2019-0528). All methods were carried out in accordance 
with relevant guidelines and regulations.
Surgical procedure. Details on the surgical procedure of reduced-port totally robotic distal subtotal gas-
trectomy (RPRDG) have been described  previously9,10. In RPRDG, an overturned SINGLE-SITE port (Intui-
tive Surgical, Sunnyvale, CA, USA) was placed via a 25-mm midline incision below the umbilicus. A camera, 
a semirigid Cadiere forceps, and an assistant port were equipped via the openings in the SINGLE-SITE port. 
An additional two ports were placed on both sides of the abdomen for rigid instruments. An 8-mm port was 
placed in the right abdomen for equipping ultrasonic shears, and a 12-mm port was placed in the left abdomen 
for introducing Maryland bipolar forceps and staplers during anastomosis. During BI anastomosis, endolinear 
staplers or robotic ENDOWRIST staplers (Intuitive Surgical, Sunnyvale, CA, USA) were inserted through the 
left port, and for BII or RY anastomosis, we converted the 8-mm port in the right abdomen to a 12-mm port for 
inserting and applying the staplers.
The standard procedure for conventional robotic distal subtotal gastrectomy (CRDG), which utilizes a total 
of five ports and four robotic arms, has been published  elsewhere21. A camera was inserted through a port posi-
tioned below the umbilicus. Cadiere forceps were inserted through an 8-mm port on the right lateral side of the 
abdomen, and ultrasonic shears were inserted through another 8-mm port on the middle point between the right 
lateral port and umbilicus. Another 8-mm port on the left lateral side of the abdomen was placed for Maryland 
bipolar forceps, and a 12-mm port was placed on the middle point between the left lateral port and umbilicus 
for an assistant. Staplers for anastomosis were inserted from the 12-mm port by the assistant for BI anastomosis 
or from the right middle side after extension of the 8-mm port to a 12-mm port for BII or RY anastomosis.
Conventional laparoscopic distal subtotal gastrectomy (CLDG) was performed with two 5-mm ports on 
both sides of the upper abdomen, two 12-mm ports on both sides of the abdomen, and one 12-mm camera port 
just below the umbilicus. During the laparoscopic surgery, the operator could freely choose among the ports for 
employing various instruments, although ultrasonic shears were primarily inserted via the right middle port. 
Also, staplers were inserted in the 12-mm ports in the right or left side as appropriate for BI, BII, or RY recon-
struction. Laparoscopic reduced-port surgery, including single-incision gastrectomy, for gastric cancer was not 
performed in our institution.
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Postoperative management and data collection. Postoperative management plans for stomach can-
cer patients were similar among operative procedures and surgeons. On postoperative day (POD) 2, patients 
without serious complications were allowed sips of water. A liquid diet and soft diet specially designed for 
patients undergoing gastrectomy was supplemented in POD 3 and POD 4, respectively. Routine laboratory tests 
for hematologic, routine chemistry, and inflammatory markers were checked on POD 1, 2, 3, and 5. On POD 
5, we recommended discharge for patients with normal laboratory test results who well adapted to the soft diet. 
Postoperative complications were documented in our database weekly after a meeting with surgical faculty and 
residents who reviewed and classified the complications according to Clavien-Dindo classification. Readmis-
sion within 90 days of operation that was found to be related to surgical complications was also recorded in the 
database.
Statistical analysis. Patient characteristics and operative related variables were tested to check for dif-
ferences among the study groups: we compared the RPRDG group versus the CRDG group and the RPRDG 
group versus the CLDG group. Differences between groups were analyzed using Student’s t-test, and descriptive 
statistics are represented as means ± SDs. Categorical variables with counts and percentages were analyzed by the 
chi-square test. For categorical variables in which more than 20 percent of all cells had expected counts fewer 
than 5, Fisher’s exact test was performed.
For learning curve analysis, as in a previous  study12, we fitted the nonlinear regression model below to 
investigate the relationship between operation time ( t , the number of operations) and surgery experience ( yt , 
operation time at t-th operation):
The model states that, as operations accumulate, starting from an initial time ( a+ c1 ), the mean operation 
time decreases nonlinearly until it reaches a stable time ( a ) after a number ( c2 ) of operations. This learning fea-
ture is well-represented by the learning curve model in (Eq. 1). Also, we fitted the model by adding covariates 
of interest, such as sex, age, BMI, extent of lymph node dissection, and reconstruction type, that could affect 
operation time. These covariates were described in a previous  study22 as an extended model:
Statistical significance was set at a P value < 0.05 for all analyses, and all analyses were conducted using R 
version 3.5.1 (The R Foundation for Statistical Computing, Vienna, Austria).
Data availability
The datasets generated and analyzed during the current study are available from the corresponding author on 
reasonable request.
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